Molecular Imaging and Biology
Molecular Imaging and Biology (commonly abbreviated as ''Mol. Imaging Biol.', previously titled Clinical Positron Imaging) is the official journal of the World Molecular Imaging Society, published in partnership with the European Society for Molecular Imaging and the Federation of Asian Societies for Molecular Imaging. Founded in 1999, it publishes original research that uses molecular imaging to understand biology and medicine, with a 2025 impact factor of 2.5.Molecular Imaging and Biology（常用缩写 Mol. Imaging Biol.，曾用刊名 Clinical Positron Imaging）是世界分子成像学会的官方期刊，并与欧洲分子成像学会、亚洲分子成像学会联合会合作出版，1999 年创刊，刊发以分子成像理解生物学与医学的原创研究，2025 年影响因子为 2.5。[1]
Scope
- Disciplinary focus: the journal concentrates on the use of molecular imaging to understand biology and medicine, and presents original research on delineating and treating disease through imaging technologies.学科定位： 期刊聚焦分子成像在理解生物学与医学中的应用，刊发通过影像技术刻画疾病边界与指导治疗的原创研究。
- Technical range: it covers radiolabelling and contrast agents, positron emission tomography, magnetic resonance imaging, optical imaging, ultrasound and intraoperative guidance, treating preclinical and first-in-human studies alike.技术范围： 涵盖放射标记与显像剂、正电子发射断层成像、磁共振成像、光学成像、超声与术中导航等模态，临床前研究与首例人体研究并重。
- Audience: it addresses clinicians and researchers in nuclear medicine, radiology, oncology and biomedical engineering, with the stated aim of placing imaging at the service of precision medicine.读者对象： 面向核医学、放射科、肿瘤学与生物医学工程领域的临床医生和研究者，宗旨在于让影像在精准医学中发挥作用。
- Article types and speed: alongside research papers and reviews it runs commentaries, guides and collections. The journal reports an average of about thirty days to a first decision and places fifteenth in the Google Scholar H-5 index for nuclear medicine and radiotherapy.体裁与时效： 除研究论文与述评外另设评论、指南与专辑，期刊自述首轮决定平均约三十天，在核医学与放射治疗类的谷歌学术指数中列第十五位。
- Open access: the journal is hybrid, offering authors a paid immediate open-access option beyond subscription, and several hundred of its articles are already freely available as open access.开放获取： 属混合开放获取刊物，订阅之外作者可付费选择立即开放，期刊已有数百篇论文以开放获取方式免费供读者阅读。
- Society network: alongside the founding society, the European and Asian molecular imaging societies are publishing partners, and papers from their congresses, award selections and meeting coverage are a standing part of the journal.学会网络： 除主办学会外，欧洲与亚洲两大分子成像学会亦为出版合作方，学会年会的论文、奖项评选与会议报道是期刊的常设内容。
History
- 1999: the journal was founded, initially centred on clinical positron emission imaging and for a time carried the title Clinical Positron Imaging.1999年： 期刊创刊，早期以临床正离子发射断层成像为重心，刊名一度为 Clinical Positron Imaging。
- Renaming and broadening: after taking its present name the journal extended its remit from the clinic into biology and basic research and became the official publication of the World Molecular Imaging Society, its influence growing as molecular imaging developed out of radiopharmacology.更名与定位扩张： 改为现名后，范围由临床一端扩展到生物学与基础研究，并成为世界分子成像学会的官方刊物，学科影响随分子成像从放射药理学起步的发展而扩大。
- Change of editor: Jason S. Lewis took over as editor-in-chief in 2020 and served until 2023, after which H. Charles Manning assumed the post in 2024 and wrote the published account of the handover.主编交接： 2020 年由 Jason S. Lewis 接任主编，任至 2023 年，其后由 H. Charles Manning 于 2024 年接棒并撰文移交。
- Present editor: Kimberly A. Kelly of the University of Virginia became editor-in-chief in September 2024, her research record and editorial vision praised at the time by the society's chief executive.现任主编： 2024 年 9 月起由弗吉尼亚大学的 Kimberly A. Kelly 出任主编，上任时该学会的首席执行官对其研究能力与办刊愿景给予评价。
- Editorial reform: at the handover the board was reorganised into tiers such as consulting and senior editors, a mentored review system involving trainees was introduced, and the annual awards for best clinical paper, best preclinical paper and image of the year were continued.编务改革： 换届时编辑部改设顾问编辑、资深编辑等层级，并引入由青年评审人参与的指导评审制度，年度最佳临床论文、最佳临床前论文与年度图像评选得以延续。[2]
Editors
- Editor-in-chief: the journal is led by Kimberly A. Kelly of the University of Virginia, assisted by an editorial assistant drawn from the operations staff of the World Molecular Imaging Society.现任主编： 主编为任职于弗吉尼亚大学医工学院的 Kimberly A. Kelly，另设编辑助理一职由世界分子成像学会的运营部门承担。
- Managing editors: two managing editors, based at the University of Copenhagen and at Memorial Sloan Kettering Cancer Center in New York, shepherd manuscripts through the workflow.事务编辑： 两位事务编辑分别任职于丹麦哥本哈根大学与纽约纪念斯隆凯特琳癌症中心，负责稿件流程推进。
- Consulting editors: eight consulting editors, based in Cambridge, New York, Gwangju, Michigan, Rehovot, Tübingen, Davis and Shanghai, act as the senior stewards of the field.顾问编辑： 顾问编辑八人分别来自英国剑桥、美国纽约、韩国光州、美国密歇根、以色列雷霍沃特、德国图宾根、美国加州戴维斯与复旦大学，是各资深方向的把关者。
- Senior editors by stream: the senior editors are organised into streams covering cardiology, clinical and first-in-human work, educational and commissioned material, and emerging technologies, each stream screening submissions and making the final recommendation.资深编辑分组： 资深编辑按学科与稿源类型分组，涵盖心脏病学、临床与首例人体研究、教育与委托编辑、新兴技术等方向，各组分别初审并作最终推荐。
- Geographic spread of the board: board members sit in the United States, Germany, the United Kingdom, the Netherlands, Spain, Australia, Korea and China, including researchers at the Institute of Automation of the Chinese Academy of Sciences and at Fudan University.编委的地域分布： 编委成员散布于美国、德国、英国、荷兰、西班牙、澳大利亚、韩国与中国等地，包括中国科学院自动化研究所与复旦大学的研究者，国际化程度高。[3]